Lee Na Young, Hwang Hyung Bin, Oh Seung Hoon, Park Chan Kee
a Department of Ophthalmology and Visual Science , Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea .
b Department of Ophthalmology and Visual Science , Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea , Seoul , Korea , and.
Semin Ophthalmol. 2015;30(5-6):345-51. doi: 10.3109/08820538.2013.874487. Epub 2014 Mar 19.
To report the efficacy of additional glaucoma drainage device (GDD) insertion in eyes with refractory glaucoma and which have a failed primary GDD.
We conducted a non-comparative, retrospective study on eight eyes of eight patients who had a failed primary GDD and received an additional GDD in the same eye. Intraocular pressure (IOP), visual acuity (VA), the number of anti-glaucomatous medications, and complications were analyzed during the most recent office visit. Success was defined as an IOP between 6 and 21 mmHg and a 20% decrease in IOP after additional GDD insertion, with or without anti-glaucomatous medication.
The mean decrease in IOP at the final follow-up was 19.3 mmHg (56.1%). The mean number of anti-glaucomatous medications used at the final follow-up (2.38) was significantly less than the preoperative mean (3.50). Seven patients achieved the criteria for success, whereas one patient had an unsuccessful outcome because of corneal graft failure after additional GDD insertion.
We showed that after the failure of a primary GDD, an additional GDD offered favorable IOP control and stable VA. In agreement with a review of previous literature, GDD insertion is the best option for treating refractory glaucoma, even in patients with a failed primary GDD.
报告在原发性青光眼引流装置(GDD)植入失败的难治性青光眼患者眼中再次植入GDD的疗效。
我们对8例原发性GDD植入失败且在同一只眼中再次接受GDD植入的患者的8只眼进行了非对照性回顾性研究。在最近一次门诊就诊时分析眼压(IOP)、视力(VA)、抗青光眼药物使用数量及并发症情况。成功定义为再次植入GDD后眼压在6至21 mmHg之间,且眼压降低20%,无论是否使用抗青光眼药物。
末次随访时眼压平均降低19.3 mmHg(56.1%)。末次随访时使用的抗青光眼药物平均数量(2.38)显著少于术前平均值(3.50)。7例患者达到成功标准,而1例患者因再次植入GDD后角膜移植失败导致治疗结果未成功。
我们表明,原发性GDD植入失败后,再次植入GDD可实现良好的眼压控制和稳定的视力。与既往文献综述一致,即使在原发性GDD植入失败的患者中,植入GDD也是治疗难治性青光眼的最佳选择。